BIOSIGHT Trademark

Trademark Overview

On Friday, February 28, 2025, a trademark application was filed for BIOSIGHT with the United States Patent and Trademark Office. The USPTO has given the BIOSIGHT trademark a serial number of 79420524. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 3, 2025. This trademark is owned by Compass HealthAI Applications Inc.. The BIOSIGHT trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic apparatus, namely, a device attachable to a clinic and/or home-based headset that uses oximetry to measure retinal artery biomarkers to assess or predict both general health and vision health and disease progression.
biosight

General Information

Serial Number79420524
Word MarkBIOSIGHT
Filing DateFriday, February 28, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, April 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkBIO SIGHT
Goods and ServicesMedical diagnostic apparatus, namely, a device attachable to a clinic and/or home-based headset that uses oximetry to measure retinal artery biomarkers to assess or predict both general health and vision health and disease progression.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, April 3, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCompass HealthAI Applications Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCA

Trademark Events

Event DateEvent Description
Thursday, April 3, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, April 4, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 4, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

biosight health predict assess biomarkers artery both general progression disease vision